Clinical trials
Observational Multiple Myeloma trials in Belgium
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
16 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 1 |
| 2008 | 1 |
| 2010 | 1 |
| 2014 | 1 |
| 2016 | 1 |
| 2017 | 4 |
| 2018 | 1 |
| 2019 | 1 |
| 2020 | 2 |
| 2021 | 1 |
| 2022 | 1 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 10 |
| Recruiting | 3 |
| Terminated | 1 |
| Unknown status | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Universitaire Ziekenhuizen KU Leuven | 4 |
| Celgene | 2 |
| Amgen | 1 |
| Centre Hospitalier Universitaire de Saint Etienne | 1 |
| European Myeloma Network B.V. | 1 |
| European Organisation for Research and Treatment of Cancer - EORTC | 1 |
| Janssen Pharmaceutica N.V., Belgium | 1 |
| Janssen-Cilag Ltd. | 1 |
| Sandoz | 1 |
| Sanofi | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Multiple Myeloma | 16 |
| Hematologic Diseases | 3 |
| Breast Neoplasms | 2 |
| Neoplasms | 2 |
| Blast Crisis | 1 |
| Breast Carcinoma In Situ | 1 |
| Breast Neoplasms, Male | 1 |
| Burkitt Lymphoma | 1 |
| COVID-19 | 1 |
| Carcinoma, Non-Small-Cell Lung | 1 |
Trials
Showing 1 to 16 of 16. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.